In this work, we hypothesised miR-142-3p as a putative mediator of the TNF-dependent enhancement of the glutamatergic transmission in the striatum, considering our previous observations that linked IL-1β to miR-142-3p and synaptic dysfunction in both EAE and MS [15]. This evidence concerns the gene IL1B and myeloid sarcoma.